Cargando…
Development of a Mouse Model of Menopausal Ovarian Cancer
Despite significant understanding of the genetic mutations involved in ovarian epithelial cancer and advances in genomic approaches for expression and mutation profiling of tumor tissues, several key questions in ovarian cancer biology remain enigmatic: the mechanism for the well-established impact...
Autores principales: | Smith, Elizabeth R., Wang, Ying, Xu, Xiang-Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935315/ https://www.ncbi.nlm.nih.gov/pubmed/24616881 http://dx.doi.org/10.3389/fonc.2014.00036 |
Ejemplares similares
-
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
por: Dodda, Balasunder R., et al.
Publicado: (2019) -
Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
por: Smith, Elizabeth R., et al.
Publicado: (2022) -
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
por: Fan, Yali, et al.
Publicado: (2022) -
Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer
por: House, Carrie Danielle, et al.
Publicado: (2014) -
Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study
por: Shin, Seokyung, et al.
Publicado: (2021)